EconPapers    
Economics at your fingertips  
 

A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization

Andrew J. Muzyk (), Sarah K. Rivelli, Wei Jiang, Heather Heinz, Amber Rayfield and Jane P. Gagliardi
Additional contact information
Andrew J. Muzyk: Campbell University College of Pharmacy and Health Sciences
Sarah K. Rivelli: Duke University
Wei Jiang: Duke University
Heather Heinz: University of North Carolina School of Pharmacy
Amber Rayfield: Campbell University College of Pharmacy and Health Sciences
Jane P. Gagliardi: Duke University

Drug Safety, 2012, vol. 35, issue 9, No 3, 725-731

Abstract: Abstract Background: Intravenous haloperidol can increase the risk for corrected QT (QTc) interval prolongation, torsades de pointes (TdP) and sudden death. Objective: The purpose of this study was to examine the effects of implementation of a computerized physician order entry (CPOE) set on adherence to monitoring parameters, maximum and cumulative doses, and identification or mitigation of risk factors for QTc prolongation in patients prescribed intravenous haloperidol. Methods: A retrospective cohort study of medically ill hospitalized inpatients prescribed intravenous haloperidol was conducted. Data were collected for two distinct 1-year time periods: the pre-CPOE set period (30 June 2007 through 30 June 2008) and the post-CPOE set period (1 January 2009 through 1 January 2010). The CPOE set was implemented on 1 October 2008. Results: A total of 151 subjects were included; 84 subjects were in the pre-CPOE set group and 67 subjects were in the post-CPOE set group. Following CPOE set implementation, subjects in the post-CPOE group, compared with the pre-CPOE group, were more likely to receive a 24-hour cumulative dose of intravenous haloperidol

Keywords: Haloperidol; Computerize Physician Order Entry; Drug Utilization Review; Computerize Provider Order Entry; Computerize Physician Order Entry System (search for similar items in EconPapers)
Date: 2012
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/BF03261969 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:35:y:2012:i:9:d:10.1007_bf03261969

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/BF03261969

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-20
Handle: RePEc:spr:drugsa:v:35:y:2012:i:9:d:10.1007_bf03261969